Latest Antibody-drug conjugate Stories
OXFORD, England and BERLIN, November 25, 2014 /PRNewswire/ -- Oxford BioTherapeutics and Berlin Chemie/ Menarini Biotech/ Menarini Ricerche (belonging to Menarini Group)
TUCSON, Ariz., Oct.
RnRMarketResearch.com adds “Perjeta & Kadcyla (HER2-Positive Breast Cancer) – Forecast and Market Analysis to 2023” to its store.
Genentech, Amgen, Igenica, and 8 Additional California Companies Scheduled to Present SAN DIEGO, Calif., Oct.
OXFORD, England and BERLIN, October 2, 2014 /PRNewswire/ -- Oxford BioTherapeutics (OBT) and Berlin Chemie/Menarini Group announce today that they have designated a novel
Gallus BioPharmaceuticals, LLC, a premier, full service biopharmaceutical contract development and manufacturing organization announced today that it has been selected by Progenics Pharmaceuticals,
OXFORD, England and SAN JOSE, California, July 8, 2014 /PRNewswire/ -- Oxford BioTherapeutics, an international biotechnology company focused on the development of innovative
Redwood Bioscience and Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today
- Collaboration and license agreement allows Merck Serono to expand its oncology drug portfolio ROCKLAND, Mass., June 24, 2014 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck
CORAL SPRINGS, Florida, June 20, 2014 /PRNewswire/ -- Healthcare industry update: companies develop advanced technologies and approaches for cancer treatment, clinical
- To writhe; struggle or twist about with more or less force; wriggle.
- To scribble, jot.